The efficacy of rituximab in refractory myositis: the jury is still out
- PMID: 23125047
- DOI: 10.1002/art.37758
The efficacy of rituximab in refractory myositis: the jury is still out
Comment on
-
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.Arthritis Rheum. 2013 Feb;65(2):314-24. doi: 10.1002/art.37754. Arthritis Rheum. 2013. PMID: 23124935 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
